Sahajanand Medical Technologies Ltd

NSE: SMT · BSE: 545001 · Healthcare · 6 announcements

Share price: ₹483.00
Market cap: ₹4,910 Cr
Revenue (annual): ₹1,210 Cr
Net profit (annual): ₹65.28 Cr
Promoter holding: 36.20%
FII holding: 35.09%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 2 Other Announcement 1 Credit Rating 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 Nov 2026 15:49 IST BSE

Credit Rating

Sahajanand Medical Technologies Credit Rating

CRISIL has upgraded Sahajanand Medical Technologies' long-term bank facility rating to CRISIL A-/Stable from BBB+/Stable. The upgrade reflects improved business risk, growing scale, and sustained profitability across its global stent manufacturing operations.

Value: ₹300.0 Cr

Open announcement → Read the filing ↗

Sahajanand Medical Technologies Ltd by type

Legal & Regulatory 2